Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.

Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.

A polyspecific Pan-African antivenom has been produced from the plasma of horses immunized with a mixture of the venoms of Echis ocellatus, Bitis arietans and Naja nigricollis, the three most medically important snakes in sub-Saharan Africa. The antivenom is a whole IgG preparation, obtained by capr...

Full description

Bibliographic Details
Main Authors:	Gutiérrez, J, Rojas, E, Quesada, L, León, G, Núñez, J, Laing, G, Sasa, M, Renjifo, J, Nasidi, A, Warrell, D, Theakston, R, Rojas, G
Format:	Journal article
Language:	English
Published:	2005

Similar Items

Polyspecific snake antivenom may help in antivenom crisis.
by: Laing, G, et al.
Published: (2003)

Polyspecific snake antivenom may help in antivenom crisis
by: Laing, G, et al.
Published: (2003)

A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa.
by: Laing, G, et al.
Published: (2003)

Cross-reactivity, antivenomics, and neutralization of toxic activities of Lachesis venoms by polyspecific and monospecific antivenoms.
by: Marvin Madrigal, et al.
Published: (2017-08-01)

Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms
by: Smalligan, R, et al.
Published: (2004)

Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms.
by: Smalligan, R, et al.
Published: (2004)

Comparison of the potency of three Brazilian Bothrops antivenoms using in vivo rodent and in vitro assays. BIASG (Butantan Institute Antivenom Study Group).
by: Laing, G, et al.
Published: (1992)

Crisis in snake antivenom supply for Africa.
by: Theakston, R, et al.
Published: (2000)

Crisis in snake antivenom supply for Africa
by: Theakston, R, et al.
Published: (2000)

Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches.
by: Petras, D, et al.
Published: (2011)

Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa.
by: Calvete, J, et al.
Published: (2010)

Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea.
by: Mariángela Vargas, et al.
Published: (2011-05-01)

Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without beta-propiolactone, in the treatment of Bothrops asper bites in Colombia.
by: Otero, R, et al.
Published: (2006)

Venom and antivenom
by: Warrell, D
Published: (1997)

COMPARISON OF THE POTENCY OF 3 BRAZILIAN BOTHROPS ANTIVENOMS USING INVIVO RODENT AND INVITRO ASSAYS
by: Laing, G, et al.
Published: (1992)

Report of a WHO workshop on the standardization and control of antivenoms.
by: Theakston, R, et al.
Published: (2003)

Notes on the use of antivenom.
by: Warrell, D
Published: (1983)

First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom.
by: Meyer, W, et al.
Published: (1997)

Antivenoms and treatment of snake-bite
by: Warrell, D
Published: (1998)

Antivenoms: a list of hyperimmune sera currently available for the treatment of envenoming by bites and stings.
by: Theakston, R, et al.
Published: (1991)

Preclinical testing of three South American antivenoms against the venoms of five medically-important Peruvian snake venoms.
by: Laing, G, et al.
Published: (2004)

Use of enzyme immunoassays to compare the effect and assess the dosage regimens of three Brazilian Bothrops antivenoms. The Butantan Institute Antivenom Study Group (BIASG).
by: Theakston, R, et al.
Published: (1992)

Use of enzyme immunoassays to compare the effect and assess the dosage regimens of three Brazilian Bothrops antivenoms. The Butantan Institute Antivenom Study Group (BIASG).
by: Theakston, R, et al.
Published: (1992)

Bioinformatics and multiepitope DNA immunization to design rational snake antivenom.
by: Simon C Wagstaff, et al.
Published: (2006-06-01)

ANTIVENOM TREATMENT FOR SCORPION STINGS - REPLY
by: Warrell, D
Published: (1991)

High incidence of early anaphylactoid reaction to SAIMR polyvalent snake antivenom.
by: Moran, N, et al.
Published: (1998)

Correction: Bioinformatics and Multiepitope DNA Immunization to Design Rational Snake Antivenom.
by: Simon C Wagstaff, et al.
Published: (2008-10-01)

Erratum to Report of WHO workshop on the standardization and control on antivenoms (vol 41, pg 541, 2003)
by: Theakston, R, et al.
Published: (2003)

Clinical studies of the effectiveness and safety of antivenoms
by: Williams, D, et al.
Published: (2018)

Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
by: Nathorn Chaiyakunapruk, et al.
Published: (2022-03-01)

Cross-Reactivity and Neutralization Capacity of Polyspecific Antivenom Produced by Razi Institute against Three Species of Buthidea Family Scorpions
by: Bahzad Masihipour, et al.
Published: (2019-09-01)

The efficacy of antivenom in the treatment of bites by the Papuan taipan (Oxyuranus scutellatus canni).
by: Trevett, A, et al.
Published: (1995)

Severe neurotoxic envenoming by the Malayan krait Bungarus candidus (Linnaeus): response to antivenom and anticholinesterase.
by: Warrell, D, et al.
Published: (1983)

Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa.
by: Segura, A, et al.
Published: (2010)

Antivenom supply and demand: An analysis of antivenom availability and utilization in South Africa
by: Natalie R Neumann, et al.
Published: (2023-12-01)

Preclinical testing of three south American antivenoms against the venoms of five medically-important Peruvian snake venoms (vol 44, pg 103, 2004)
by: Laing, G, et al.
Published: (2004)

Response to a letter from J-P Chippaux and L Boyer entitled: "The 3+3 dose escalation design is not appropriate for antivenom dose finding."
by: Habib, A, et al.
Published: (2010)

Cross-recognition of a pit viper (Crotalinae) polyspecific antivenom explored through high-density peptide microarray epitope mapping.
by: Mikael Engmark, et al.
Published: (2017-07-01)

Apparent marked reduction in early antivenom reactions compared to historical controls: was it prophylaxis or method of administration?
by: Caron, E, et al.
Published: (2009)

Neutralizing capacity of a new monovalent anti-Bothrops atrox antivenom: comparison with two commercial antivenoms
by: R. Otero, et al.
Published: (1997-03-01)